Stock Market in Seoul Experiences Slight Dip Following Trump's Imposition of Tariffs on Copper and Medicines
In a recent development, President Donald Trump has announced plans to impose a 25% tariff on all South Korean products starting August 1, 2025, unless new trade agreements are reached. This announcement has caused a wave of uncertainty and potential volatility in the South Korean stock market, particularly for major exporters in electronics, automobiles, and pharmaceuticals.
The threatened tariffs are broad, targeting all goods, not specifically just copper or pharmaceuticals. However, Korean chip and pharmaceutical industries are particularly highlighted as being in the crosshairs of ongoing U.S. probes, which could lead to additional industry-specific tariffs. Trump has stated that the August 1 deadline is “no extensions,” but has also hinted the deadline may not be “100% firm,” leaving room for further negotiation and thus ongoing uncertainty in markets.
This renewed threat follows a pattern of trade tensions between the U.S. and South Korea, which have historically led to market volatility and pressure on the relevant sectors. While there is no current report of tariff threats specifically on copper and pharmaceuticals in August 2020, general trade war volatility in the past had similar impacts on Korean stocks.
The impact of these threats can be seen in the stock market movements. For instance, Samsung Electronics dropped 1.3 percent, while Naver lost 1.94 percent. On the other hand, Samyang Food added 0.84 percent, and Lotte Shopping rose 2.89 percent. The trading of the local currency was down 5.95 won from the previous session.
The broader economic effects of these threats are also a concern. The Korean won often weakens on such news, and export-dependent firms may preemptively adjust earnings forecasts downward, which can pressure stock prices.
In conclusion, Trump’s renewed tariff threats have increased uncertainty for South Korean exporters and their investors, with a direct impact on stock prices of major export companies, particularly in technology and pharmaceuticals. The threat of 25% tariffs on all goods, combined with ongoing investigations into specific sectors (chips, pharmaceuticals), creates significant downside risk for South Korean equities, as well as potential currency and economic ripple effects.
The looming tariffs on South Korean goods, targeting various industries such as electronics, automobiles, and pharmaceuticals, could lead to industry-specific probes and additional tariffs for these sectors, particularly for the chip and pharmaceutical industries. Trump's non-committal stance on the deadline for these tariffs perpetuates ongoing market volatility and uncertainty, with potential negative impacts on South Korean equities, currency, and broader economy.
